Home > Products > Active Pharmaceutical Ingredient (API)

Sinae Active Pharmaceutical Ingredient (API) fabrica, supplementum, Factory

View as  
 
123663-49-0

123663-49-0

Seres Product Name: Ellamod
Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
Latina Product Name: iguratimod
CAS # 123663-49-0
Molecular formula: c17h14n2o6s
Molecular pondus: 374,3679
Specie et proprietates alba pulveris
Domesticis Registration Number API: Y20190021542

Lege plusMitte Inquisitionem
N-(3-Formamido-4-oxo-6-phénoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3-yl]

N-(3-Formamido-4-oxo-6-phénoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3-yl]

Seres operis nomen: Ellamod
Sinensis alias: N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl) methanesulfonamide N-[7-(Methanesulfonamido) -4-oxo-6-phenoxy-4H-chromen-3- y] formamide
Anglicus operis nomen: Iguratimod
CAS#123663-49-0
Formulae hypotheticae: C17H14N2O6S
Pondus hypotheticum: 374.3679
Species et possessiones: cerussa
Adnotationis domesticae numerus API: Y20190021542

Lege plusMitte Inquisitionem
Api iguramatimod

Api iguramatimod

Seres Product Name: Ellamod
Seres alias: N [3 (Carboxamido) -4-Oxo-VI-phenoxy-4h-I-Benzopyran-VII-YL] Methanesulfonamide
Latina Product Name: iguratimod
CAS # 123663-49-0
Molecular formula: c17h14n2o6s
Molecular pondus: 374,3679
Specie et proprietates alba pulveris
Domesticis Registration Number API: Y20190021542
Iguratimod API est pro anti-RHEUMATICUS medicamento, Synovitis medicamento.

Lege plusMitte Inquisitionem
Quiescere potes ex officina nostra emere Active Pharmaceutical Ingredient (API) in Sinis. Pharmaceutical Run'an professionalis Sinarum Active Pharmaceutical Ingredient (API) fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
X
Crusulis utimur ut meliorem experientiam pasco tibi praebeamus, situm negotiationis et personalize contentus analyse. Hoc situ utendo, ad nostrum crustulorum usum consentis. Privacy Policy
Reject Accipe